Article Details

Paradigm Biopharmaceuticals (ASX:PAR) stuck in IND waiting game

Retrieved on: 2021-04-26 00:56:15

Tags for this article:

Click the tags to see associated articles and topics

Paradigm Biopharmaceuticals (ASX:PAR) stuck in IND waiting game. View article details on hiswai:

Excerpt

The U.S. Food and Drug Administration has notified Paradigm Biopharmaceuticals (PAR) it will need longer to review its IND application; Last month, ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up